High-sensitivity glycan profiling providing detailed structural information is very important in the search for glycan disease markers. By combining a straight-forward and fast preparation protocol of mucins with high-throughput nanoLC/MS, we have been able to study the O-glycosylation of the colon MUC2 mucin from one single biopsy (∼5 mg wet tissue as starting material) collected from the sigmoid colon during routine colonoscopy of 25 normal control patients. This large mucin glycoprotein was recovered from the guanidinium chloride-extracted insoluble pellet, reduced and alkylated, separated by SDS-agarose polyacrylamide composite gel electrophoresis, and transferred to a PVDF membrane. The O-linked oligosaccharides of the major MUC2 monomer band were released by reductive β-elimination and analyzed by nanoLC/mass spectrometry and MS n . The aim was to identify the MUC2 O-glycans of the sigmoid colon and provide a comprehensive catalog of the O-glycan repertoire. More than 100 complex O-linked oligosaccharides were identified, of which some had not been described before. Most of the oligosaccharides were based on the core 3 structure with sialic acid at the 6-position of the GalNAc and the substructure Galβ1-3/4-GlcNAcβ1-3(NeuAc-6)GalNAcol was found in most glycans. The most abundant components were SO − 3 -Gal-(Fuc)GlcNAc-3(NeuAc-6)GalNAcol, GalNAc-(NeuAc-)Gal-4/3GlcNAc-3(NeuAc-6)GalNAcol, GalNAc-3(NeuAc-6) GalNAcol, and GlcNAc-3(NeuAc-6)GalNAcol. In contrast to the O-glycans of other mucins, the sigmoid MUC2 O-glycan repertoire and relative amounts in normal individuals were relatively constant.
Introduction
Carbohydrates are attached to many proteins and lipids and play a key role in numerous biological processes as for example protein conformation, molecular recognition, protein protection, and adhesion partners for microorganisms. There is an enor-mous carbohydrate complexity in nature, and the large diversity is found both within the same species and between different species. One reason for such a large diversity is believed to be a selective pressure between host and microorganisms during evolution (Gagneux and Varki 1999) .
Mucins are large glycoproteins making up the core of the mucus gel covering all mucosal surfaces of the body. A typical feature for mucins is the mucin or PTS domain, often made up by tandemly repeated peptide sequences containing Pro, Thr, and Ser residues. The mucins are extensively O-glycosylated and become very large when fully glycosylated. The carbohydrate part can constitute 80% of the total mucin mass and a MUC2 mucin monomer becomes ∼2.5 MDa in size. The O-glycans are added in the Golgi apparatus by the addition of a GalNAc residue to the hydroxyl group of Ser and Thr of the protein backbone. The human genome encodes at least four gel-forming mucins, where the goblet cell-produced MUC2 mucin is the predominant one in the human colon (Gum et al. 1994) .
Previous studies of colon mucin glycosylation have been based on antibody reactivities, analyses of the chemical composition of the mucins, and structural analyses of material obtained from a few patients undergoing colectomy (Podolsky 1985b; Capon et al. 2001; Robbe et al. 2003 Robbe et al. , 2004 . Recently, Robbe-Masselot et al. (2008) have presented a thorough study of O-glycans on the MUC2 mucin derived from artificial urinary bladders constructed from proximal colonic tissue. These artificial bladders become inflamed and are thus less indicative of the glycosylation in the normal colon. It has so far not been possible to analyze the mucin glycosylation of a high number of individuals and on the limited material available from the routine biopsies taken at colonoscopy. Recent developments in miniaturized ways to prepare samples and high-sensitivity mass spectrometry instruments and methodology have raised new possibilities. Mass spectrometry has been the main analysis technique for mucin O-glycans for a long period, especially powerful when combined with chromatographic methods as high-temperature gas chromatography and HPLC (Karlsson et al. 1989 (Karlsson et al. , 1997 Schulz, Oxley, et al. 2002; Thomsson et al. 2002; Robbe et al. 2004; Schulz et al. 2005) . As natural oligosaccharides are neutral or negatively charged, it is beneficial to analyze native glycans in the negative ion mode. This mode also produces characteristic cross-ring cleavages for NeuAc bound to C-6 of GalNAcol essential for differentiation between isomers. It has been shown that ESI-MS/MS in the negative ion mode can give both sequence and partial linkage information of underivatized oligosaccharides (Chai et al. 2002) . Graphite particles as a stationary phase for LC/MS of oligosaccharides have provided sensitive methods for the analysis of neutral and acidic glycans (Davies et al. 1993) .
For the present study, a small-scale preparation method for mucins from one single colonic biopsy has been developed. Fig. 1 . Alcian blue-stained PVDF membrane after composite agarose-polyacrylamide gel electrophoresis and blotting of guanidinium chloride insoluble mucins from sigmoid colon biopsies of five control patients (Ctrl). The MUC2 monomer band (band 1) is marked as well as the MUC2 dimer/oligomer band (band 2) that is occasionally inefficiently transferred.
O-Glycosylation of the colon MUC2 mucin
It has been used together with agarose-polyacrylamide gel electrophoresis and the miniaturized release of oligosaccharides . To further improve the sensitivity, an LC/ESI-MS interface similar to the one previously described (Shen et al. 2002) has been developed and graphite columns with small inner diameters (100-75 μm) were prepared in-house. Our aim was to obtain a comprehensive structural characterization of mucin O-glycosylation of the MUC2 mucin from 25 normal control subjects. This is the first analysis of a high number of individuals to obtain a comprehensive view of the glycosylation of the MUC2 mucin in the sigmoid colon.
Results

Gel electrophoresis and blotting of the colonic sigmoid MUC2
Normal millimeter-sized sigmoid colon biopsies were collected at routine colonoscopy from 25 normal patients. The guanidinium chloride insoluble mucins were obtained by repeated extraction of the biopsies in 6 M GuHCl. The ABO blood group was known for most of the patients, but not the Lewis and secretor status. The GuHCl insoluble material containing most of the MUC2 mucin (Carlstedt et al. 1993 ) was solubilized by reduction of their disulfide bonds. The reduced Cys were alkylated and the soluble mucins were separated by composite SDS-agarose polyacrylamide gel electrophoresis allowing the resolution of these large molecules. For oligosaccharide analysis, the mucin bands were blotted to a PVDF membrane which was stained with Alcian blue (Figure 1 ). The major band (MUC2 band 1) is about 2.5 MDa and due to the monomeric MUC2 (Axelsson et al. 1998; Herrmann et al. 1999) , something that was also confirmed by tryptic digestion and analysis by nanoLC-MS and MS/MS (not shown). No other mucin was detected in this band. Only about 50% of the material in the MUC2 band 1 is transferred to the membrane, probably due to its large size. It has not been possible to increase the transfer yield further. All subjects also have a slower migrating band that corresponds to a nonreducible MUC2 dimer (MUC2 band 2) clearly visible when the gel itself is stained (Axelsson et al. 1998 ). However, this band is poorly transferred to the blotting membrane and is thus in low amounts in Figure 1 . No major differences in migration of the MUC2 band 1 between the different subjects were observed on the composite SDS-agarose polyacrylamide gels.
Oligosaccharide release and separation
From the stained PVDF membrane, the main MUC2 band (MUC2 band 1, Figure 1 ) was excised and the O-glycans were released by reductive β-elimination in a small scale . The glycans were desalted and purified by a simple procedure and analyzed on a nanoLC/MS system with a novel simplified nanoLC/MS electrospray interface similar to one described before (Shen et al. 2002) . The column was coupled to a linear ion trap mass spectrometer operating in the negative ion mode allowing the analysis of underivatized oligosaccharides in the low pmole range. The oligosaccharides were eluted with acetonitrile in water with the addition of ammonia to the mobile phase (0.04%) to increase the ionization in the negative mode. Figure 2 shows a typical base peak chromatogram from the separation of released glycans with some of the major oligosaccharides identified marked. The chromatogram reveals a complex pattern that corresponds to many different oligosaccharides, of which some are relatively abundant. The obtained mass spectra were manually analyzed for each glycan revealing that the oligosaccharides appear as singly, doubly, and triply charged ions depending on the number of acidic residues.
Structure elucidation by nanoLC/MS n
The primary ions were isolated and dissociated in the linear ion trap, generating MS 2 , MS 3 , and MS 4 (collision of the most abundant ion in the previous spectrum) spectra. This detailed information allowed the interpretation of the structures of most oligosaccharides. Diagnostic ions for NeuAc in the C-6 position of GalNAcol have previously been published and were used to support the fragmentation pattern (Robbe et al. 2004) . Fragmentation annotations applied are based on the nomenclature suggested by Domon and Costello (1988; Karlsson et al. 1996) . The fragment ions formed were mainly B i , Y j , and Z j ions. The α suffix was used to designate cleavages in the 6-linked branch of GalNAcol and the β suffix was used to designate cleavages in the 3-linked branch. All sequence fragment ions observed could be explained by a glycosidic bond cleavage (see supplementary Figure S1 ). In the following interpretations all hexoses are assumed to be Gal, all deoxyhexoses Fuc, all internal N-acetylhexosamines GlcNAc, and all reduced N-acetylhexosamines GalNAcol. Terminal N-acetylhexosamine attached to Gal also substituted with NeuAc was assumed to be the Sd a /Cad antigen as this has been shown to be a prominent epitope in the human colon (Capon et al. 2001) .
More than 100 MUC2 O-glycans of chain lengths between 2 and 12 residues were identified, of which some structures have not been described previously. Table I summarizes all the glycans characterized from at least one recorded MS 2 spectrum in the 25 patients. Most of the characterized structures were present in all patients. The main part of the structural interpretations is described in the supplementary data. The mass spectra (MS 2 to MS 4 ) for the oligosaccharides given in Table I are found at www.medkem.gu.se/mucinbiology/glycandatabases/.
Almost all oligosaccharide structures were based on the core 3 structure (GlcNAcβ1-3GalNAcol). This has also previously been suggested to be the most common core in the human colon (Podolsky 1985a (Podolsky , 1985b Capon et al. 2001; Robbe et al. 2004 ). Many of the compounds were built around the tetrasaccharide Galβ1-3/4-GlcNAcβ1-3(NeuAc-6)GalNAcol, and the sialyl-Tn substructure (NeuAcα2-6GalNAcα1-O-S/T) was present in all of the identified core 3 structures. The core oligosaccharide was further extended consecutively with GlcNAc and Gal residues on the C-3 branch and terminated with Fuc, NeuAc or SO mass of 2597 Da and containing three NeuAc groups. It was not possible to fully elucidate the structure of this large component, but smaller compounds as for example the three isomers of an octasaccharide substituted with two NeuAc and one Fuc residue have been fully interpreted. The three components were separated on the LC column as shown in Figure 3 where the interpreted structures are shown. The mass spectra and interpretations are explained in the supplementary data and Figure S2 . The three isomers had identical MS 2 spectra, but the structures could be further elucidated from their MS 3 spectra ( Figure S2 ). A high degree of sialylation was observed on the glycans from sigmoid colonic MUC2 (Table I) which has also been no- ticed before (Robbe et al. 2003 (Robbe et al. , 2004 . Many oligosaccharides were at least monosialylated and several of them were also dior even trisialylated. The NeuAc is lost first during CID and the exact localization of the internal NeuAc has not been possible to unequivocally determine. In the structure 1460, substituted with two NeuAc residues (Table I) , it is most likely that the internal NeuAc is attached to the GlcNAc residue, rather than two NeuAc residues on the terminal Gal. NeuAc has previously been suggested to be localized on an internal Gal residue (Podolsky 1985a) . Thus, internal NeuAc residues may be localized on either internal GlcNAc or Gal residues. In the compounds with internal NeuAc residues, the localization of the NeuAc is marked by [NeuAc] in Table I . The spectra of the abundant trisialylated nonasaccharide with a molecular mass of 2029 Da are shown in supplementary Figure S3 .
Almost 40 sulfated oligosaccharides were elucidated from the sigmoid colonic MUC2, and they could also be mono-or disubstituted with sialic acid; some of the glycans also had a Fuc residue attached (see Table I ). When a charged residue is present in a structure, the fragmentation is initiated as remote as possible from the charge, in this case the sulfate group. NeuAc is not at all as strong promotor for charge remote fragmentation as sulfate and is the first group to be cleaved off in CID. The phenomenon of charge-remote fragmentation was first described by Adams (1990) . Sulfated core 2 structures based on Gal-3(GlcNAc-6)GalNAcol were found at m/z 829 for the tetrasaccharide Gal-3(SO − 3 -Gal-GlcNAc-6)GalNAcol, 758 O-Glycosylation of the colon MUC2 mucin Table I . Structural characterization of O-linked oligosaccharides released from colonic MUC2 of the sigmoid colon of 25 patients. The MS n of these compounds are available at www.medkem.gu.se/mucinbiology/glycandatabases
Label
Observed ions Molecular ion mass and for fucosylated pentasaccharide at m/z 975, Gal-3(SO − 3 -Gal-(Fuc)GlcNAc-6)GalNAcol, both structures elongated on the C-6 branch. Fucosylated on both branches and corresponding to a molecular mass of 1121 Da was a hexasaccharide with the structure Fuc-Gal-3(SO − 3 -Gal-(Fuc)GlcNAc-6)GalNAcol. Two isomers of a monosulfated and disialylated nonasaccharide denoted as 1980a and b are shown in supplementary Figure S4 . A core 2-based structure with two SO − 3 groups was observed as a doubly charged ion at m/z 628.9, corresponding to a molecular mass of 1258 Da, and the structure was interpreted as SO − 3 -Gal-(Fuc)GlcNAc-Gal-3(SO − 3 -GlcNAc-6)GalNAcol. This core 2-type hexasaccharide is shown in Figure S5 . A sialylated structure based on core 2 was found as a doubly charged ion at m/z 633.3 (molecular mass of 1266 Da) having the structure NeuAc-Gal-3(Gal-(Fuc)(SO − 3 ) GlcNAc-6)GalNAcol. As for the sialylated components, most O-Glycosylation of the colon MUC2 mucin of the other sulfated ones were based on core 3 with a NeuAc at C-6.
Five core 4 (GlcNAc-3(GlcNAc-6)GalNAcol)-based structures were identified, of which three contained only sialic acids (1884c, d, e). The other two contained one or two sulfate groups and the monosulfated also had one NeuAc residue (1307ab). The disulfated compound had a molecular mass of 1404 Da and this core 4-type heptaoligosaccharide is shown in Figure S5 .
Four core 3 isomers were observed as triply charged ions at m/z 586.6, corresponding to a molecular mass of 1761 Da. The isomers were denoted as 1761a, b, c, and d and were eluted in that order (see Figure 4A ). As the ions are triply charged it implies the presence of three acidic groups, and the structures are also shown to have two NeuAc's and one SO − 3 residue. All four isomers have almost identical MS 2 spectra, exemplified in Figure 4B , with a doubly charged ion at m/z 734.4 (Y 5β ) as the base peak due to the loss of one NeuAc residue on the C-3 branch ( NeuAc = 291). The doubly charged ion at m/z 769.4 originates from the 0,2 X 1α ring cleavage indicating that the C-6 branch is substituted with a second NeuAc residue and that the fragment ion at m/z 1178.4 is due to the loss of this NeuAc. The isomers denoted as 1761a and 1761b have similar MS 3 spectra ( Figure 4C1 and D1) from CID of the doubly charged ion at m/z 734.4 (Y 5β ). The base peak at m/z 1178.3 is denoted as a Y 3β /1α ion and is due to the loss of the second NeuAc ( NeuAc = 291). An 0,2 X 1α ring cleavage gives rise to a doubly charged ion at m/z 623.6, indicating that the second NeuAc is located on the C-6 of GalNAcol. The fragment ion at m/z 955.1, which is 223 Da (the GalNAcol residue) lower in mass as compared to the fragment ion at m/z 1178, indicates the formation of a B-ion on the C-3 branch, Y 3β /B 4β , and presumably a terminal sulfate group. The MS 4 spectra of 1761a and b from CID of the ion Y 3β /1α at m/z 1178.3 were different from each other ( Figure 4C2 and D2). The base peak in both spectra at m/z 1032.3 is due to fragmentation of a Fuc residue ( Fuc = 146), but the location is different in the two isomers. In 1761a, the MS 4 spectrum ( Figure 4C2 
Thus, the sulfate group in these isomers is located on the internal GlcNAc linked to the GalNAcol. These four isomers clearly illustrate the necessity of MS 4 to be able to definitively determine the structure of the compounds.
Fucosylated structures were also common, more than 50 structures were elucidated and 10 of these were difucosylated (Table I) . Only a few of the Fuc residues were terminal, presumably due to very low expression of the FUT2 enzyme necessary to generate the blood group H (Fucα1-2Galβ1-) antigen in the sigmoid colon. This is in agreement with previous studies (Yuan et al. 1985; Robbe et al. 2003 Robbe et al. , 2004 .
Quantitative estimates of MUC2 oligosaccharides
The general impression was that there were small differences in the relative amount of glycans in the analyzed biopsies. To study this further, the amounts of O-glycans on the insoluble MUC2 was semi-quantified in the 25 control patients by integration of the individual peak areas in the chromatograms. For these studies, another chromatography system (see Material and methods) was used that has been shown to give more reproducible and quantitative measurements of amounts (Thomsson et al. unpublished) . Twenty-six glycans were selected for quantification due to their wide distribution among the patients. The other glycans were of lower intensity and recorded in fewer patients as they did not reach the detection limits. The intensities of the singly and doubly charged ions were combined, as were the intensities of glycan isomers when present (except for 716a and b). The glycan semiquantification of the oligosaccharides with a relative intensity >0.4 (17 glycans) is presented in Figure 5 . When the patients were divided into blood groups (A, AB, and B clustered in one group), the relative intensity means were relatively similar between the groups and no statistically significant difference (P < 0.05) could be proven between the groups (0.08 < P < 0.96) for the 17 glycans. The standard deviations of the mean amounts differ between the sigmoid MUC2 O-glycans, but still all patients had very similar patterns of the most abundant components. These were SO − 3 -Gal-(Fuc)GlcNAc-3(NeuAc-6)GalNAcol (#1104), [NeuAc-] 1 GalNAc-Gal-GlcNAc-3(NeuAc-6)GalNAcol (#1372), and isomers GlcNAc-3(NeuAc-6)GalNAcol (#716a), and GalNAc-3(NeuAc-6)GalNAcol (#716b), each in mean amounts of 13-16% of the total amount of glycans quantified. Thus, the relative amounts of the sigmoid MUC2 O-glycans appear to be relatively constant in normal control patients. Also the dominating species were the same and without any obvious relation to the blood group ABH status of the patients. 5 . The relative mean amounts (±1 SD) from semi-quantification of the molecular ion intensities of the 17 most abundant oligosaccharides in the sigmoid colon of normal patients. The 25 control patients were separated depending on blood group; blood group O contains 10 patients (n = 10) and blood group A, AB, and B were clustered into one group with 8 patients in a total (n = 8). For seven patients, the blood group was not known (n = 7). No statistically significant difference (defined as P < 0.05) was observed between these groups for any of the oligosaccharides.
Discussion
In the present study, the O-glycosylation of a specific mucin, MUC2, from the human sigmoid colon was explored in a relatively large number of individuals. As the MUC2 mucin is the only gel-forming mucin and a major component in the colon mucus, its O-glycosylation represents most of the colon mucus O-glycans. Mucin O-glycosylation constitutes up to 80% of the mucin mass and is a typical feature of mucins. The O-glycans can bind bacteria, parasites, and viruses and are most likely acting as a removable decoy in the defense of the mucosal barrier of the host (Moncada et al. 2003 ).
The present study was based on a general approach pioneered by Niclas Karlsson (Schulz, Oxley, et al. 2002) , including the separation of mucins on composite AgPAGE, release of Oglycans from blotting membranes, small-scale desalting, separation on graphite columns, and mass spectrometry analysis in the negative ion mode. We have further optimized the initial extraction of the mucins and more importantly developed a new LC-MS interface and optimized and miniaturized the chromatography. Together, this allowed us to analyze single colon biopsies from a large number of individuals, something that was not possible before. The nanoLC-MS method used is very sensitive especially for the characterization of large polysulfated/ polysialylated oligosaccharides, but the capillaryLC-MS method gives linear and more reproducible estimates of relative amounts (Thomsson et al. unpublished) . Thus, we have based the quantitative estimates on the latter technique and both methods for the structural characterization. We have studied the protein content of the MUC2 band 1 used in the present study by proteomics. MUC2 was the only mucin identified in this band (unpublished). Due to this, the O-glycans found are almost exclusively originated from this mucin and their two mucin domains.
More than 100 complex oligosaccharides could be identified where most were mono-, di-or trisialylated. The high degree of sialylation is intriguing, and an increasing acidic gradient along Fig. 6 . General structure of the major oligosaccharides based upon core 3 and NeuAc bound to C-6 as found in the human sigmoid colon. All isomers have not been observed, but all the individual sites of substitution for the sulfate group (S), sialic acid (N), and fucose (F). The internal sialic acid is marked [N] and can be localized on internal GlcNAc and/or Gal. the intestinal tract have been reported (Robbe et al. 2003) . The sialic acid in the C-6 position of GalNAcol was a very typical feature of the identified MUC2 O-glycans, likely due to a very active ST6GalNAc1 transferase. The C-6 branch is by this terminated and cannot be elongated further. However, smaller amounts of core 2 and core 4 structures were also detected. Most glycans carried negative charges due to sialic acid or sulfate groups, and often both. The sialic acids were localized not only terminally, but also on the internal polylactosamine core structure. When the localization of the sulfate group was possible to determine, it was on Gal in most components, an interpretation that probably is general as most structures are compatible with sulfate only on the Gal. The fucose residues were largely found on GlcNAc, in most instances as one isomer, but sometimes as two isomers suggesting the presence of both type 1 and 2 structures as in Lewis x and Lewis a. Thus, colon MUC2 carries a relatively consistent repertoire of glycans as illustrated in Figure 6 . Although all individual isomers with different sulfate, Fuc or NeuAc substitution have not been recorded, most of these are likely to be present. As already discussed, the internal NeuAc can be positioned on either a GlcNAc or a Gal.
The Sd a /Cad epitope (GalNAc1-4(NeuAc2-3)Gal-) was first observed by Capon et al. (2001) as prevalent in the colon. We could also identify the epitope with appropriate masses and MS n in five components and assumed that these carry the Sd a /Cad antigen. The observed structural elements in this study are in agreement with the mucin glycans described previously in the normal sigmoid colon (Capon et al. 2001; Robbe et al. 2004 ), but we could also identify additional larger isomers, especially with multiply charged substituents.
Despite the possible large glycan diversity, we observe a relatively limited variability in the structural elements. There is also a surprisingly small individual variability between the 25 subjects, much smaller than has been observed for O-glycans in for example salivary (Thomsson et al. 2005) , respiratory (Schulz et al. 2005) , and cervix mucins (Andersch-Björkman et al. 2007) , where for example the ABO blood group system is creating a high diversity. In the sigmoid colon, only a few minor compounds were found of this type due to the low expression of FUT2 and subsequently low expression of ABO and Lewis b antigens. This is remarkable and it can be suggested that the glycosylation pattern of the sigmoid colon is less variable as compared to mucins from other locations. The reason for this is not known, but it can be speculated that a uniform glycan array on the MUC2 mucin is important for selecting the colon commensal flora. This is different from all other mucus-coated surfaces where the glycans on the mucins are believed to act as attachment sites and to trap pathogenic and noncommensal bacteria. For such a function, a diverse glycan repertoire would be more functional. The relatively conserved human MUC2 colon glycan repertoire, but still complex, in all the individuals may suggest a selective advantage. This could lead to the selection for a specific commensal flora. In fact, the normal colonic bacterial flora was recently shown to be homogenous and similar between individuals (Gill et al. 2006 ) in contrast to previous suggestions (Hoskins et al. 1985; Gill et al. 2006) . Such a hypothesis is also in line with the recent observation by Rawls et al. (2006) that germ-free mice select out and enrich the bacteria typical for mouse from a different repertoire as found in the zebra fish gut. The present structural characterization of the O-glycans on the MUC2 mucin from 25 individuals provides the first larger overview of the glycan repertoire of an important organ exposed to a large number of commensal bacteria that possibly could enhance the susceptibility to diseases like ulcerative colitis. A majority of the O-glycans observed was based on the core 3 structure and had a NeuAc bound to C-6 of the GalNAcol and this could be unique for human beings and possibly gained early on in the evolution. Further studies are needed in order to confirm such a hypothesis.
Material and methods
Recruitment of patients and collection of colonic biopsies
The patients were recruited among patients undergoing routine colonoscopy at Sahlgrens' University Hospital, Gothenburg, Sweden. Biopsies from the sigmoid colon were collected from visually normal mucosa of 25 control patients, and all ABO blood groups were represented among these. The subjects underwent colonoscopy for investigation of anemia, rectal bleeding, and polyp surveillance. The biopsies were kept on dry ice until storage in −80
• C. The study was performed after written informed consent was obtained from all of the subjects, and the approval was granted by the Human Research Ethical Committee of the Medical Faculty, University of Gothenburg.
Reagents
All chemicals, unless otherwise stated, were purchased from Sigma (St. Louis, MO). Maxymum recovery 1.7 mL tubes (Axygen, Union City, CA) were used throughout the procedure.
Mucin preparation
One or two biopsies (∼5-10 mg wet weight) were homogenized in extraction guanidinium chloride (extr-GuHCl) (40 μL, 6 M with 5 mM EDTA, 0.01 M NaH 2 PO4) with protease inhibitor PMSF (2 mM final concentration) using a plastic mini pestle. An additional 160 μL extr-GuHCl (total volume 200 μL) was added, and the homogenized material was stirred gently overnight at +4
• C. The solution was centrifuged for 30 min at 13.200 rpm, and the GuHCl soluble (supernatant) and insoluble (pellet) fractions were separated by collecting the supernatant. The soluble fraction was stored in −20
• C. To the insoluble fraction (the pellet), another portion of extr-GuHCl (100 μL) was added followed by stirring for ∼4 h or overnight. The centrifugation was repeated according to above with subsequent division of the soluble and the insoluble fractions. The two soluble fractions were pooled.
Guanidinium chloride for reduction (red-GuHCl) (120 μL, 6 M with 5 mM EDTA, 0.1 M Tris) was added to the insoluble fraction. Reducing agent dithiotreitol (DTT, 1.0 M solution) was added to the insoluble and soluble fractions to a final concentration of 50 mM. The solutions were stirred for 1.5 h at 37
• C. Alkylating agent 4-vinylpyridine was added to a final concentration of 125 mM, and the solutions were stirred for 1 h in room temperature in the dark. Samples were transferred to dialysis cups (10 kDa MWCO, Slide-A-Lyzer MINI dialysis cups, Pierce, Rockford, IL) and dialyzed against water at 4
• C overnight. The samples were transferred to Eppendorf tubes and dried to almost dryness using a Speedvac. Samples were dissolved in a 2× sample buffer (0.75 M Tris-HCl, pH 8.1, 2% SDS, 0.01% bromophenol blue, 60% glycerol) in small aliquots with heating to 100
• C in between. Water was added to a final concentration of the 1× sample buffer (∼500 μL final volume) plus additional 1.0 M DTT (25 μL) for complete reduction.
SDS-agarose composite gel electrophoresis for separation of mucins
A gel containing agarose (0.5-1% gradient), acrylamide (0-6%), and glycerol (0-10%) was prepared as previously described . Thirty percent of the samples (1.2 biopsies) were loaded (after concentrating the samples on spin columns (100 kDa MWCO, Microcon YM-100 centrifugal filter devices). The electrophoresis was run in the borate/ Tris buffer (192 mM boric acid, 1 mM EDTA, 0.1% SDS, pH adjusted to 7.6 with Tris base) on ice in +4
• C at 12 mA/gel overnight (16 h).
Mucin glycan release
Colonic mucins were separated on SDS-agarose composite gels and wet blotted at 40 W (∼350 mA-450 mA) for 5 h to an Immobilon (PVDF P SQ ) membrane. Transfer was performed in a buffer (25 mM Tris, 192 mM glycine, 0.04% SDS, 20% methanol) on ice in the cold room (+4
• C). The bands were visualized with Alcian blue, and oligosaccharides were released by reductive β-elimination as previously described from the lower MUC2 band (MUC2 band 1 in Figure 1A) . The released glycans were resuspended in dd-H 2 O (15 μL) prior to analysis.
Nano-LC/MS interface
The nano-LC/MS interface used in this study is similar to the one described by Shen et al. (2002) . A through bore 1/16 union (Z1UT, Vici AG, Switzerland) was connected to the end of the packed fused silica capillary column, and a steel screen (1 μm pores, Valco, Vici AG, Switzerland) was placed directly on top of the sleeved capillary column in the union from which a tapered nanoESI-emitter tip was connected. The nanoESIemitter tips (around 30 mm length) were made from a 20 μm i.d. and 150 μm o.d. fused silica capillary (Polymicro Technologies, Phoenix, AZ) and held in position by 20 mm PEEK tubing (150 μm i.d., Upchurch Scientific, Oak Harbor, WA) as a sleeve. This connection produces a negligible dead volume for nanocolumn flow rates. The high voltage (−1.6 kV) was connected via the through bore union.
